Zobrazeno 1 - 10
of 58
pro vyhledávání: '"K J, Tveter"'
Autor:
K J Tveter, L M Eri
Publikováno v:
Prostate Cancer and Prostatic Diseases. 4:173-177
The effects of the nonsteroidal antiandrogen bicalutamide (Casodex(TM)) and the luteinizing hormone releasing hormone agonist leuprolide depot (Procren Depot(TM), Lupron Depot(TM)) on serum prostate-specific antigen (PSA), acid phosphatase (ACP), and
Autor:
L M Eri, K J Tveter
Publikováno v:
European Urology. 26:219-226
Casodex, a new nonsteroidal antiandrogen, was investigated in this double-blind, randomized, placebo-controlled study comprising 28 evaluable patients with benign prostatic hyperplasia, who received Casodex at a dosage of 50 mg daily or a placebo for
Publikováno v:
The Prostate. 46(4)
Nonsteroidal antiandrogens are commonly used in the treatment of prostate cancer, but more clinical and laboratory studies on patients with benign as well as malignant prostate diseases are required to define their exact role.Light microscopic examin
Autor:
K J, Tveter
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 117(14)
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 117(7)
Septicemia as a result of urinary infection is a serious condition, almost always caused by gram-negative bacteria. The bacterial toxins have a profound influence on haemostasis, microcirculation, and cardiac anf respiratory function. This article co
Autor:
T, Jørgensen, K J, Tveter
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 117(3)
In Norway the standard treatment for metastatic prostatic cancer has been surgical or medical castration. Only recently have antiandrogens been approved for treatment of advanced cancer of the prostate. The authors examine the principles for total or
Autor:
K J, Tveter, H O, Beisland, J T, Andersen, H, Wolf, P, Ekman, J E, Johansson, M, Kontturi, T, Lehtonen
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 116(27)
707 patients with moderate prostatic hyperplasia were recruited to a two-year Scandinavian multicenter study. The study was randomized, prospective and double-blind. Half of the patients were treated with finasteride (5 mg daily) and the controls wer
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 116(27)
The prevalence of benign prostatic hyperplasia increases with increasing age. The growing number of elderly men in the population will cause a marked increase in the number of men suffering from this condition. The magnitude of the problem necessitat
Autor:
K J, Tveter
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 116(24)